Ireland-based Endo International Plc has appointed Craig Paterson, a former executive at Salix Pharmaceuticals, as its chief medical officer to oversee the company’s global clinical development programme. A medical doctor and master in business administration, Dr Paterson was recently in charge of medical and clinical development at Salix. Before that he held senior positions at King Pharmaceuticals and GlaxoSmithKline Plc. He has been associate professor of surgery at the University of Massachusetts Medical School in the US and assistant professor of surgery at McMaster University Medical Center in Canada.
Endo announced the appointment on 8 September 2015.
Copyright 2015 Evernow Publishing Ltd